Also, just looked on the FB site. Someone asked where the $40M came from. Official TRTC rep responded “it came from the same capital partners we’ve been working with the last several years”
Translation: No new major investor
Translation: no uplisting at the moment
Translation: fleeced....
The RS is the equivalent of leaving our (former) share count and price as it was, and instead upping the authorized share count from 980M to 14.5 Billion..
Multiple locations were launched in Nevada (in a sub standard medical market) prior to adult use, as well as locations in CA (Carnegie, Dyer), as well as NuLeaf Nevada, all for the moment/at the times resulting in "nothing to show for it".....